X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare ALEMBIC LTD with Novartis - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC LTD vs NOVARTIS - Comparison Results

ALEMBIC LTD    Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

NOVARTIS 
   Change

Novartis is a 76% subsidiary of Novartis AG - Switzerland and has a countrywide presence in the healthcare business. While pharmaceuticals contributes 70% to total revenues (FY10), generics (6%), consumer healthcare i.e. OTC (14%) and animal health (... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC LTD NOVARTIS ALEMBIC LTD/
NOVARTIS
 
P/E (TTM) x 75.1 349.6 21.5% View Chart
P/BV x 2.8 17.2 16.2% View Chart
Dividend Yield % 0.4 1.7 24.0%  

Financials

 ALEMBIC LTD   NOVARTIS
EQUITY SHARE DATA
    ALEMBIC LTD
Mar-16
NOVARTIS
Mar-16
ALEMBIC LTD/
NOVARTIS
5-Yr Chart
Click to enlarge
High Rs53982 5.4%   
Low Rs29556 5.3%   
Sales per share (Unadj.) Rs4.7252.9 1.9%  
Earnings per share (Unadj.) Rs8.862.1 14.1%  
Cash flow per share (Unadj.) Rs9.063.3 14.2%  
Dividends per share (Unadj.) Rs0.1510.00 1.5%  
Dividend yield (eoy) %0.41.3 28.1%  
Book value per share (Unadj.) Rs27.7363.6 7.6%  
Shares outstanding (eoy) m267.0331.96 835.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x8.73.0 286.0%   
Avg P/E ratio x4.712.4 37.8%  
P/CF ratio (eoy) x4.612.2 37.5%  
Price / Book Value ratio x1.52.1 70.0%  
Dividend payout %1.716.1 10.6%   
Avg Mkt Cap Rs m10,96224,580 44.6%   
No. of employees `000NA0.8 0.0%   
Total wages/salary Rs m2381,801 13.2%   
Avg. sales/employee Rs ThNM10,748.9-  
Avg. wages/employee Rs ThNM2,395.2-  
Avg. net profit/employee Rs ThNM2,641.1-  
INCOME DATA
Net Sales Rs m1,2608,083 15.6%  
Other income Rs m264829 31.8%   
Total revenues Rs m1,5248,913 17.1%   
Gross profit Rs m83234 35.4%  
Depreciation Rs m6137 167.3%   
Interest Rs m02 16.7%   
Profit before tax Rs m2851,025 27.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m2,09617 12,552.1%   
Extraordinary Inc (Exp) Rs m-321,696 -1.9%   
Tax Rs m6752 0.8%   
Profit after tax Rs m2,3431,986 118.0%  
Gross profit margin %6.62.9 226.8%  
Effective tax rate %2.173.4 2.9%   
Net profit margin %185.924.6 756.6%  
BALANCE SHEET DATA
Current assets Rs m1,68912,678 13.3%   
Current liabilities Rs m4862,433 20.0%   
Net working cap to sales %95.4126.7 75.3%  
Current ratio x3.55.2 66.7%  
Inventory Days Days21733 663.5%  
Debtors Days Days8122 360.4%  
Net fixed assets Rs m1,62469 2,347.0%   
Share capital Rs m534160 334.2%   
"Free" reserves Rs m5,96011,460 52.0%   
Net worth Rs m7,40411,621 63.7%   
Long term debt Rs m1040-   
Total assets Rs m8,01014,400 55.6%  
Interest coverage x950.7570.5 166.6%   
Debt to equity ratio x00-  
Sales to assets ratio x0.20.6 28.0%   
Return on assets %29.313.8 211.9%  
Return on equity %31.617.1 185.2%  
Return on capital %31.323.6 132.7%  
Exports to sales %2.90.7 395.3%   
Imports to sales %28.918.6 155.2%   
Exports (fob) Rs m3760 61.6%   
Imports (cif) Rs m3641,503 24.2%   
Fx inflow Rs m37186 19.9%   
Fx outflow Rs m3651,821 20.0%   
Net fx Rs m-328-1,635 20.1%   
CASH FLOW
From Operations Rs m3462,531 13.7%  
From Investments Rs m-48-8,270 0.6%  
From Financial Activity Rs m-301-386 78.0%  
Net Cashflow Rs m-3-6,125 0.0%  

Share Holding

Indian Promoters % 64.0 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 0.2 2.0 10.0%  
FIIs % 9.7 1.6 606.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.1 21.5 121.4%  
Shareholders   54,701 41,647 131.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC LTD With:   SUVEN LIFE  SHASUN PHARMA  PIRAMAL ENTERPRISES  FDC LTD.  SUN PHARMA  

Compare ALEMBIC LTD With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Strong Note; Bank & Realty Stocks Rally(Closing)

Indian share markets surged further in the afternoon session and finished in the green for the second straight session on heavy buying in realty stocks, metal stocks and bank stocks.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC LTD SHARE PRICE


Aug 23, 2017 (Close)

TRACK ALEMBIC LTD

  • Track your investment in ALEMBIC LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ALEMBIC LTD 5-YR ANALYSIS

COMPARE ALEMBIC LTD WITH

MARKET STATS